Table 5.

Association of calciphylaxis with all-cause mortality (Cox-regression analysis-univariable model)

Variable	HR (95% CI)	p-value
Calciphylaxis	6.96 (4.1–11.7)	< 0.001
Age	1.03 (1.01–1.05)	0.002
Male	1.16 (0.73–1.83)	0.54
Caucasian	3.7 (1.4–10.4)	0.01
Diabetes mellitus	1.79 (1.1–2.9)	0.013
BMI	1.01 (0.97–1.04)	0.86
IHD	1.61 (0.96–2.68)	0.06
MI	2.76 (1.54–4.98)	0.001
PVD	1.88 (0.99–3.57)	0.054
CVA	0.96 (0.39–2.38)	0.93
Dialysis vintage	0.99 (0.99–1.01)	0.36
Haemoglobin	0.96 (0.94–0.97)	< 0.001
Albumin	0.89 (0.87–92)	< 0.001
C-reactive protein	1.02 (1.01–1.02)	< 0.001
Corrected calcium	1.55 (0.41–5.77)	0.51
Phosphate	0.97 (0.63–1.46)	0.83
Parathyroid hormone	1.00 (1.00–1.01)	0.001
ESA	1.66 (1.03–2.67)	0.04
Vitamin D analogue	1.24 (0.78–1.97)	0.36
Phosphate binder	0.78 (0.44–1.39)	0.40
Calcimimetic	1.09 (0.57–2.08)	0.78
Vitamin K antagonist (warfarin)	2.67 (1.55–4.6)	< 0.001

Hazard ratio for Parathyroid hormone included only 122 patients with available parathyroid hormone levels

BMI Body mass index, IHD ischemic heart disease, MI myocardial infarction, PVD peripheral vascular disease, CVA cerebrovascular accident, ESA erythropoietin stimulating agent, HR hazard ratio, CI confidence interval